术前肝功能作为术后肝衰竭的预测因子,在周周胆血管癌中
Yasunori Yoshimi1, Satoko Yorinaga1, Takehiro Noji2,3
1Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo, Japan.
In vivo (Athens, Greece)
|October 30, 2025
概括
临床相关的肝功能衰竭 (CRLF) 是外周胆管癌 (PHCC) 手术后的主要风险. 低的手术前门静脉栓塞 (PVE) 肝功能 (ICGKF),加上长时间的手术时间和高血损失,显著增加了CRLF风险.
科学领域:
- 肝胆道手术是肝胆道的手术.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 在周围胆管癌 (PHCC) 手术中的手术死亡率主要是由于临床相关的肝功能衰竭 (CRLF).
- 在接受手术前门静脉栓塞 (PVE) 的患者中,CRLF的危险因素尚未确定.
- 了解这些风险对于改善肝切除术后患者的治疗结果至关重要.
研究的目的:
- 调查临床相关肝衰竭 (CRLF) 的危险因素.
- 在外围胆管癌 (PHCC) 患者手术前门静脉栓塞 (PVE) 大型肝切除术后识别CRLF预测因子.
主要方法:
- 对经过重大肝切除术的PHCC患者的回顾性分析.
- 评估手术前的门静脉栓塞 (PVE) 和红素绿色 (ICG) 肝功能测试 (ICGKF).
- 使用多变量分析识别CRLF的独立风险因素.
主要成果:
- CRLF的总体发生率为27.5%.
- 对CRLF的独立风险因素包括手术时间>660分钟,血液损失>1,900毫升,以及除左肝切除外的其他手术.
- 在接受PVE的患者中,PVE前的ICGKF<0.05,长的手术时间和高的手术内出血是CRLF的重要风险因素.
- 患有所有三种危险因素的患者死亡率为25%.
结论:
- 长时间的手术和显著的血液损失与PHCC手术后的死亡率增加有关.
- 手术前肝功能低下 (ICGKF <0.05) 显著增加了CRLF的风险,特别是当与漫长的手术和大量出血相结合时.
- 这些发现强调了评估肝功能和手术因素的重要性,以减轻PHCC患者的CRLF风险.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
176
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
176
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
209
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
209